This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Church & Dwight (CHD) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Church & Dwight (CHD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's How Clorox (CLX) is Placed Just Ahead of Q2 Earnings
by Zacks Equity Research
Clorox's (CLX) Q2 results are expected to reflect gains from solid demand, cost-saving efforts, strong execution and pricing actions. Its IGNITE strategy and digital investments bode well.
Clorox (CLX) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Procter & Gamble (PG) Q2 Earnings Top Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 8.24% and 0.49%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Solid Brand Portfolio to Aid Procter & Gamble's (PG) Q2 Earnings
by Zacks Equity Research
Procter & Gamble's (PG) Q2 results are expected to reflect the benefits of a robust brand portfolio, cost-saving and productivity measures, and effective business strategies, offset by elevated costs.
4 Stocks Set to Grow in the Thriving Soap & Cleaning Materials Industry
by Rajani Lohia
The soap and cleaning materials industry looks poised for growth on favorable demand trends, pricing efforts, innovation, digital transformation and brand building amid elevated costs. Players like PG, CL, CHD and CLX look well-poised.
Clorox (CLX) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
In the closing of the recent trading day, Clorox (CLX) stood at $143.35, denoting a -0.57% change from the preceding trading day.
Procter & Gamble (PG) Strong Brands Aid Growth Amid Inflation
by Zacks Equity Research
Procter & Gamble (PG) is navigating market challenges and leveraging growth opportunities in fiscal 2024, showcasing robust sales in key divisions and innovative ventures like Ninjamas.
Is Clorox (CLX) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Clorox (CLX) and Imperial Tobacco Group PLC (IMBBY) have performed compared to their sector so far this year.
Why the Market Dipped But Clorox (CLX) Gained Today
by Zacks Equity Research
Clorox (CLX) reachead $142.72 at the closing of the latest trading day, reflecting a +0.95% change compared to its last close.
Clorox (CLX) Navigates Challenges, Poised for Sustained Growth
by Zacks Equity Research
Clorox's (CLX) focus on maintaining competitive pricing, sustained innovation, and adherence to a balanced spending approach bodes well amid input-cost inflation and supply-chain woes.
Clorox (CLX) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
Clorox (CLX) reachead $141.29 at the closing of the latest trading day, reflecting a -0.81% change compared to its last close.
Constellation Brands (STZ) Beats Q3 Earnings Estimates
by Zacks Equity Research
Constellation Brands (STZ) delivered earnings and revenue surprises of 5.28% and 3.15%, respectively, for the quarter ended November 2023. Do the numbers hold clues to what lies ahead for the stock?
How to Find Strong Consumer Staples Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Clorox (CLX) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
Clorox (CLX) closed at $142.59 in the latest trading session, marking a +0.37% move from the prior day.
Clorox (CLX) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
Clorox (CLX) reachead $141.86 at the closing of the latest trading day, reflecting a +0.5% change compared to its last close.
Clorox (CLX) Ascends But Remains Behind Market: Some Facts to Note
by Zacks Equity Research
Clorox (CLX) closed at $141.16 in the latest trading session, marking a +0.4% move from the prior day.
Clorox's (CLX) Growth Strategies Seem Encouraging: Here's Why
by Zacks Equity Research
Clorox's (CLX) IGNITE strategy bodes well. The company's pricing and cost-saving initiatives are aiding margins and, in turn, profitability.
Why Clorox (CLX) Dipped More Than Broader Market Today
by Zacks Equity Research
In the closing of the recent trading day, Clorox (CLX) stood at $141.91, denoting a -0.19% change from the preceding trading day.
Clorox (CLX) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
In the latest trading session, Clorox (CLX) closed at $141.55, marking a -1.46% move from the previous day.
RBGLY or CLX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
RBGLY vs. CLX: Which Stock Is the Better Value Option?
Clorox (CLX) Up 16.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Pinterest and Clorox have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Pinterest and Clorox have been highlighted as Zacks Bull and Bear of the Day.
Bear of the Day: Clorox (CLX)
by Andrew Rocco
Clorox is facing significant challenges after a sophisticated cyber-attack disrupted its operations. Despite its reputation as a value stock, CLX's overvaluation, negative quarterly EPS growth, and declining stock prices are concerning.
Pricing Aids Clorox's (CLX) Q1 Earnings Amid Cyberattack Woes
by Zacks Equity Research
Clorox's (CLX) Q1 results reflect the impacts of lower volume due to the recent cyberattack. However, results are largely offset by its pricing actions and cost-saving initiatives.